Metabolic Syndrome-Related Hyperuricemia is Associated with a Poorer Prognosis in Patients with Colorectal Cancer: A Multicenter Retrospective Study

PURPOSE: Hyperuricemia and metabolic syndrome (MetS) have been shown to correlate with prognosis in patients with malignant tumors. The present study evaluated the relationship between preoperative hyperuricemia and MetS in colorectal cancer (CRC) patients and analyzed the effect of this combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Qian, Tang, Liang-Jie, Luo, Ding-Hai, Wang, Ying, Wu, Nan, Chen, Hao, Chen, Meng-Xia, Jiang, Lei, Jin, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633709/
https://www.ncbi.nlm.nih.gov/pubmed/34866939
http://dx.doi.org/10.2147/CMAR.S338783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633709/
https://www.ncbi.nlm.nih.gov/pubmed/34866939
http://dx.doi.org/10.2147/CMAR.S338783

Ejemplares similares